The approval of OLUMIANT is based on the Phase 3 clinical trial program that demonstrated efficacy for difficult to treat patients1
PR Newswire
INDIANAPOLIS, June 1, 2018
PR Newswire
INDIANAPOLIS, June 1, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey